从“借船出海”到“造船远航”:2025药企出海十大关键词导语:十大关键词里的出海征途,从“卖青苗”到“价值链共造”的蜕变。正文:如果你今年关注医药圈,一定被一连串“天文数字”砸晕过:恒瑞医药125亿美元绑定GSK,信达生物114亿美元牵手武田,三生制药单款药就从辉瑞拿到12.5亿美元首付…这不是偶然爆发,而是中国创新药攒了10年的“大招”。截至2025年11月,中国创新药对外授权(BD)出海的...
Source Link从“借船出海”到“造船远航”:2025药企出海十大关键词导语:十大关键词里的出海征途,从“卖青苗”到“价值链共造”的蜕变。正文:如果你今年关注医药圈,一定被一连串“天文数字”砸晕过:恒瑞医药125亿美元绑定GSK,信达生物114亿美元牵手武田,三生制药单款药就从辉瑞拿到12.5亿美元首付…这不是偶然爆发,而是中国创新药攒了10年的“大招”。截至2025年11月,中国创新药对外授权(BD)出海的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.